VHL and cancer: Previous studies have reported that HIF inhibits mTOR activity through the transcriptional induction of antagonists of mTOR signaling8,43, raising a question as to whether the use of mTOR inhibitors constitutes a rational approach to the treatment of VHL-defective cancer.